Equillium (EQ) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Equillium (EQ) is Neutral.

The composite score behind that read is -0.18, weighing +0.14 of bullish evidence against -0.28 bearish.

Equillium last closed at $1.39, -2.11% on the session.

Against the IVW growth benchmark the position is -1.95% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

7 graded predictions for EQ so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Equillium in the 20th percentile on return on equity, where 100 is best.

Equillium is classified under Health Care / Biotechnology, with a market capitalisation of $90.04M.

StockMap tracks Equillium as the 287th largest of the 377 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 198 Moderate Underperform, 166 Neutral and 13 Strong Underperform.

On that composite Equillium ranks 144th of 377 in the group, against a group median of -0.21.